BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 33406652)

  • 1. It's Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant
    Behzadi P; Baráth Z; Gajdács M
    Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33406652
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
    Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O
    Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Occurrence of alert pathogens in hospital environment Part II. Multidrug-resistant non-fermenting bacilli].
    Paluchowska P; Skałkowska M; Spelak A; Budak A
    Med Dosw Mikrobiol; 2012; 64(1):45-53. PubMed ID: 22808729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol Increases Sensitivity of Clinical Colistin-Resistant Pseudomonas aeruginosa to Colistin
    Wang L; Zhang Y; Lin Y; Cao J; Xu C; Chen L; Wang Y; Sun Y; Zheng X; Liu Y; Zhou T
    Microbiol Spectr; 2023 Feb; 11(1):e0199222. PubMed ID: 36475724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of Multidrug-Resistant Non-Fermenting Gram-Negative Bacilli in a Tertiary Care Teaching Hospital of Central India: Is Colistin Resistance Still a Distant Threat?
    Soni M; Kapoor G; Perumal N; Chaurasia D
    Cureus; 2023 May; 15(5):e39243. PubMed ID: 37342731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem-Resistant but Cephalosporin-Susceptible
    Gajdács M
    Antibiotics (Basel); 2020 Apr; 9(4):. PubMed ID: 32244694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem-resistant and cephalosporin-susceptible
    Li S; Jia X; Li C; Zou H; Liu H; Guo Y; Zhang L
    Infect Drug Resist; 2018; 11():1225-1235. PubMed ID: 30154669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence, virulence, carbapenem resistance, susceptibility to disinfectants and public health hazard of Pseudomonas aeruginosa isolated from animals, humans and environment in intensive farms.
    Gharieb R; Saad M; Khedr M; El Gohary A; Ibrahim H
    J Appl Microbiol; 2022 Jan; 132(1):256-267. PubMed ID: 34171153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
    Mohanty S; Maurya V; Gaind R; Deb M
    J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review.
    Nørgaard SM; Jensen CS; Aalestrup J; Vandenbroucke-Grauls CMJE; de Boer MGJ; Pedersen AB
    Antimicrob Resist Infect Control; 2019; 8():170. PubMed ID: 31709047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update of clinical application in ceftazidime-avibactam for multidrug-resistant Gram-negative bacteria infections.
    Zhen S; Wang H; Feng S
    Infection; 2022 Dec; 50(6):1409-1423. PubMed ID: 35781869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterizations of antibiotic resistance, biofilm formation, and virulence determinants of Pseudomonas aeruginosa isolated from burn wound infection.
    Ghasemian S; Karami-Zarandi M; Heidari H; Khoshnood S; Kouhsari E; Ghafourian S; Maleki A; Kazemian H
    J Clin Lab Anal; 2023 Apr; 37(4):e24850. PubMed ID: 36808649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of Vector Autoregressive and Linear Transfer Models to Follow Up the Antibiotic Resistance Spiral in Gram-negative Bacteria From Cephalosporin Consumption to Colistin Resistance.
    Tóth H; Fésűs A; Kungler-Gorácz O; Balázs B; Majoros L; Szarka K; Kardos G
    Clin Infect Dis; 2019 Sep; 69(8):1410-1421. PubMed ID: 30561543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Outcomes for Carbapenem-Resistant and Cephalosporin-Susceptible
    Ng TH; Zhao JJ; Gumbleton R; Olson S; Smith S; Scipione MR
    Ann Pharmacother; 2024 Jun; 58(6):581-588. PubMed ID: 37752788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
    J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.